Jennifer B. Marks

Endocrinology
1450 NW 10th Ave
Miami, FL 33136

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Oral Glucose Tolerance Test Measures of First-phase Insulin Response and Their Predictive Ability for Type 1 Diabetes.

Oral Glucose Tolerance Test Measures of First-phase Insulin Response and Their Predictive Ability for Type 1 Diabetes.

Journal: The Journal of clinical endocrinology and metabolism
Published: June 12, 2021

Exenatide extended release in patients with type 1 diabetes with and without residual insulin production.

Exenatide extended release in patients with type 1 diabetes with and without residual insulin production.

Journal: Diabetes, obesity & metabolism
Published: May 10, 2020

The Pathological Evolution of Glucose Response Curves During the Progression to Type 1 Diabetes in the TrialNet Pathway to Prevention Study.

The Pathological Evolution of Glucose Response Curves During the Progression to Type 1 Diabetes in the TrialNet Pathway to Prevention Study.

Journal: Diabetes care
Published: April 01, 2020

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.

Journal: The New England journal of medicine
Published: June 11, 2019

Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data.

Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data.

Journal: Diabetes
Published: January 17, 2019

Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes.

Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes.

Journal: Diabetes care
Published: March 06, 2018

The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes.

The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes.

Journal: Diabetologia
Published: February 21, 2017

Adaptation of β-Cell and Endothelial Function to Carbohydrate Loading: Influence of Insulin Resistance.

Adaptation of β-Cell and Endothelial Function to Carbohydrate Loading: Influence of Insulin Resistance.

Journal: Diabetes
Published: January 21, 2015

The Effect of DPT-1 Intravenous Insulin Infusion and Daily Subcutaneous Insulin on Endogenous Insulin Secretion and Postprandial Glucose Tolerance.

The Effect of DPT-1 Intravenous Insulin Infusion and Daily Subcutaneous Insulin on Endogenous Insulin Secretion and Postprandial Glucose Tolerance.

Journal: Diabetes care
Published: July 30, 2014

Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment.

Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment.

Journal: Diabetes care
Published: December 04, 2013

B-lymphocyte depletion with rituximab and β-cell function: two-year results.

B-lymphocyte depletion with rituximab and β-cell function: two-year results.

Journal: Diabetes care
Published: September 13, 2013

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.

Journal: Lancet (London, England)
Published: April 09, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026